EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Risk of cellular or antibody-mediated rejection in pediatric kidney transplant recipients with BK polyomavirus replication—an international CERTAIN registry study

Alexander Fichtner, Jeremy Schmidt, Caner Süsal, Andrea Carraro, Jun Oh, Matthias Zirngibl, Sabine König, Isabella Guzzo, Lutz T Weber, Atif Awan, Kai Krupka, Paul Schnitzler und 3 weitere

Pediatric Nephrology · 2025

DOI: 10.1007/s00467-024-06501-7 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Nephrology, 2025. Verfasst von Alexander Fichtner und 14 weiteren Autor:innen. Beteiligte Einrichtung: Heidelberg University, Medical Faculty Heidelberg, Department of Pediatrics I, University Children's Hospital, Im Neuenheimer Feld 430, Heidelberg, 6…. Hauptthemen laut MEDLINE: BK Virus, Graft Rejection, Kidney Transplantation, Polyomavirus Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Peter Stiftung, Dietmar Hopp Stiftung, Universitätsklinikum Heidelberg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In kidney transplant recipients (KTR), BK polyomavirus-associated nephropathy (BKPyVAN) is a major cause of graft loss. To facilitate the clearance of BKPyV-DNAemia, reduction of immunosuppression is currently the treatment of choice but may increase the risk of graft rejection.

Methods

This international CERTAIN study was designed to determine the risk of alloimmune response and graft dysfunction associated with immunosuppression reduction for BKPyV treatment in 195 pediatric KTR.

Results

BKPyV-DNAemia was associated with a more than twofold increased risk of late T cell-mediated rejection (TCMR) (HR 2.22, p = 0.024), of de novo donor-specific HLA antibodies (dnDSA) and/or antibody-mediated rejection (ABMR) (HR 2.64, p = 0.002), and of graft function deterioration (HR 2.73, p = 0.001). Additional independent risk factors for dnDSA/ABMR development were a higher HLA mismatch (HR 2.72, p = 0.006) and re-transplantation (HR 6.40, p = 0.000). Other independent predictors of graft function deterioration were TCMR (HR 3.98, p = 0.003), higher donor age (HR 1.03, p = 0.020), and re-transplantation (HR 3.56, p = 0.013).

Conclusions

These data indicate that reduction of immunosuppression for BKPyV-DNAemia management is associated with increased alloimmune response in pediatric KTR. Therefore, regular dnDSA screening and close monitoring of graft function in case of BKPyV-DNAemia followed by subsequent reduction of immunosuppressive therapy are recommended. Graphical sbstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BK VirusGraft RejectionKidney TransplantationPolyomavirus InfectionsTumor Virus InfectionsAdolescentChildChild, PreschoolFemaleHumansInfantMaleGraft SurvivalHLA AntigensImmunosuppression TherapyImmunosuppressive AgentsRegistriesRisk FactorsVirus ReplicationLongitudinal StudiesRetrospective Studies

Stichwörter der Autor:innen

BK polyomavirus-associated nephropathyDonor-specific antibodiesKidney transplant rejectionPediatric kidney transplantation

Substanzen

HLA AntigensImmunosuppressive Agents

Autor:innen und Institutionen

  • Heidelberg University, Medical Faculty Heidelberg, Department of Pediatrics I, University Children's Hospital, Im Neuenheimer Feld 430, Heidelberg, 69120, Germany.
  • Heidelberg University, Medical Faculty Heidelberg, Department of Transplantation Immunology, Institute of Immunology, Heidelberg, Germany.
  • Transplant Immunology Research Center of Excellence, Koç University, Istanbul, Turkey.
  • Pediatric Nephrology, Dialysis and Transplantation Unit, Department of Woman's and Child's Health, University Hospital of Padova, Via Giustiniani 3, 35128, Padua, Italy.
  • Department of Pediatric Nephrology, University Children's Hospital, Martinistr. 52, 20246, Hamburg, Germany.
  • University Children's Hospital, Hoppe-Seyler-Str. 1, 72076, Tübingen, Germany.

Förderung

  • Peter Stiftung
  • Dietmar Hopp Stiftung
  • Universitätsklinikum Heidelberg

Zitieren

APA

Fichtner, A., Schmidt, J., Süsal, C., Carraro, A., Oh, J., Zirngibl, M., König, S., Guzzo, I., Weber, L. T., Awan, A., Krupka, K., Schnitzler, P., Hirsch, H. H., Tönshoff, B., & Höcker, B. (2025). Risk of cellular or antibody-mediated rejection in pediatric kidney transplant recipients with BK polyomavirus replication—an international CERTAIN registry study. Pediatric Nephrology. https://doi.org/10.1007/s00467-024-06501-7

Vancouver

Fichtner A, Schmidt J, Süsal C, Carraro A, Oh J, Zirngibl M, et al. Risk of cellular or antibody-mediated rejection in pediatric kidney transplant recipients with BK polyomavirus replication—an international CERTAIN registry study. Pediatric Nephrology. 2025. doi:10.1007/s00467-024-06501-7

BibTeX
@article{Fichtner2025,
  author = {Fichtner, Alexander and Schmidt, Jeremy and Süsal, Caner and Carraro, Andrea and Oh, Jun and Zirngibl, Matthias and König, Sabine and Guzzo, Isabella and Weber, Lutz T and Awan, Atif and Krupka, Kai and Schnitzler, Paul and Hirsch, Hans H and Tönshoff, Burkhard and Höcker, Britta},
  title = {Risk of cellular or antibody-mediated rejection in pediatric kidney transplant recipients with BK polyomavirus replication—an international CERTAIN registry study},
  journal = {Pediatric Nephrology},
  year = {2025},
  doi = {10.1007/s00467-024-06501-7}
}
Kostenlos starten →